# Methylphenidate for the Treatment of Acute Mania

> **NCT01541605** · PHASE3 · COMPLETED · sponsor: **Michael Kluge** · enrollment: 42 (actual)

## Conditions studied

- Mania

## Interventions

- **DRUG:** methylphenidate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01541605
- **Lead sponsor:** Michael Kluge
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541605, "Methylphenidate for the Treatment of Acute Mania". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01541605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*